ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "CMC Pitfalls: From Benchtop to IND"
Episode Synopsis
Listen as members of Veristat’s regulatory team outline the fundamentals— and the pitfalls— as you determine your readiness to file an Investigational New Drug (IND) from a manufacturing perspective.
More episodes of the podcast Advancing Revolutionary Therapies
Emergency Use Authorizations
22/09/2022
Orphan Drug Designations and Orphan Subsets
11/09/2022
Season 3 Trailer
26/08/2022
In God we trust